PubRank
Search
About
Philip Pivirotto
Author PubWeight™ 16.09
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.
Mol Ther
2006
2.41
2
A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys.
Mol Ther
2006
1.77
3
Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys.
Hum Gene Ther
2009
1.46
4
Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain.
Mol Ther
2008
1.40
5
Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys.
Hum Gene Ther
2009
1.36
6
Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC.
Mol Ther
2010
1.31
7
Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys.
Hum Gene Ther
2009
1.21
8
Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.
Exp Neurol
2005
1.17
9
Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF.
J Neurosci
2010
1.14
10
Real-time MR imaging with Gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors.
Mol Ther
2010
1.09
11
Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum.
Hum Gene Ther
2012
1.02
12
Dynamic hyperpolarized carbon-13 MR metabolic imaging of nonhuman primate brain.
Magn Reson Med
2013
0.88